Standardization of IMT Dosage (UTIT) in Mechanical Ventilation. (UTIT-IMT)
Standardization of Inspiratory Muscle Training Dose in Mechanically Ventilated Patients: A Randomized Clinical Trial Using the Total Inspiratory Work Unit (UTIT).
Respiratory muscle weakness prolongs mechanical ventilation (MV) and delays weaning. Currently, there is no standardized dosage for Inspiratory Muscle Training (IMT) in the ICU. This study aims to define an optimal IMT dosage using a new metric called "Total Inspiratory Work Unit" (UTIT), which integrates intensity, repetition, and frequency.
The study compares three daily dosage regimens (1,000 UTIT, 2,000 UTIT, and 3,000 UTIT) adjusted daily based on the patient's Negative Inspiratory Force (NIF). The goal is to determine the optimal dose-response relationship for improving inspiratory muscle strength (PiMax) and reducing the duration of mechanical ventilation.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This is a randomized clinical trial conducted at Hospital H+ Querétaro. Eligible intubated patients will be assigned to one of three intervention groups differing in the daily volume of inspiratory work.
The "Total Inspiratory Work Unit" (UTIT) is defined as: UTIT = (Target NIF %) x (Number of Breaths per Session) x (Number of Sessions per Day).
Intensity is adjusted daily to maintain the target UTIT dose. The study utilizes a threshold loading device (POWERbreathe K5) with real-time feedback. Safety parameters (SpO2, HR, FR, MAP) are monitored continuously during sessions. The intervention continues until successful weaning, extubation, ICU discharge, or death.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Querétaro
-
Querétaro City, Querétaro, México, 76000
- Hospital H+ Querétaro, Santiago de Querétaro, Querétaro
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adult patients (>18 years of age) admitted to the Intensive Care Unit (ICU).
- Invasive mechanical ventilation support for more than 48-72 hours.
- Hemodynamic stability (defined as absence of vasopressors or receiving stable doses).
- Adequate oxygenation and ventilatory parameters: PEEP < 10 cmH2O, FiO2 < 0.6, and PaO2/FiO2 ratio > 150-200.
- Ability to cooperate with instructions or absence of deep sedation.
Exclusion Criteria:
- Pre-existing neuromuscular pathology directly affecting respiratory muscles.
- Severe thoracic trauma or recent thoracic surgery.
- Unresolved pneumothorax or bronchopleural fistula.
- Severe hemodynamic instability or severe cardiac arrhythmias.
- Level of sedation that prevents active participation in sessions.
- Pregnancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Low Dose Group (1,000 UTIT)
Participants receive a daily IMT dosage of 1,000 Total Inspiratory Work Units (UTIT). Intensity: 30% of the patient's baseline Negative Inspiratory Force (NIF). Repetitions: 30 breaths per session. Frequency: 1 session per day |
Respiratory rehabilitation training using a specific threshold loading device (POWERbreathe K5) with real-time feedback.
The intervention aims to strengthen inspiratory muscles (diaphragm and intercostals).
The daily dosage is calculated using the Total Inspiratory Work Unit (UTIT) formula, adjusted daily based on the patient's Negative Inspiratory Force (NIF).
|
|
Experimental: Intermediate Dose Group (2,000 UTIT)
Participants receive a daily IMT dosage of 2,000 Total Inspiratory Work Units (UTIT). Intensity: 50% of the patient's baseline Negative Inspiratory Force (NIF). Repetitions: 60 breaths per session. Frequency: 2 sessions per day. |
Respiratory rehabilitation training using a specific threshold loading device (POWERbreathe K5) with real-time feedback.
The intervention aims to strengthen inspiratory muscles (diaphragm and intercostals).
The daily dosage is calculated using the Total Inspiratory Work Unit (UTIT) formula, adjusted daily based on the patient's Negative Inspiratory Force (NIF).
|
|
Experimental: High Dose Group (3,000 UTIT)
Participants receive a daily IMT dosage of 3,000 Total Inspiratory Work Units (UTIT). Intensity: 80% of the patient's baseline Negative Inspiratory Force (NIF). Repetitions: 60 breaths per session. Frequency: 3 sessions per day. |
Respiratory rehabilitation training using a specific threshold loading device (POWERbreathe K5) with real-time feedback.
The intervention aims to strengthen inspiratory muscles (diaphragm and intercostals).
The daily dosage is calculated using the Total Inspiratory Work Unit (UTIT) formula, adjusted daily based on the patient's Negative Inspiratory Force (NIF).
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Maximal Inspiratory Pressure (Pimax)
Periodo de tiempo: From baseline (study entry) up to successful weaning, extubation, or ICU discharge (up to 30 days).
|
Change in maximal inspiratory pressure measured in cmH₂O using the POWERbreathe K5 device to evaluate inspiratory muscle strength from baseline to the end of the intervention.
|
From baseline (study entry) up to successful weaning, extubation, or ICU discharge (up to 30 days).
|
|
Total Duration of Mechanical Ventilation
Periodo de tiempo: From the initiation of mechanical ventilation until successful extubation or ICU discharge (up to 30 days)
|
Total number of consecutive days a patient requires invasive mechanical ventilation support via endotracheal tube.
|
From the initiation of mechanical ventilation until successful extubation or ICU discharge (up to 30 days)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Duration of the Weaning Process
Periodo de tiempo: From the start of the weaning process up to successful extubation (up to 30 days)
|
Number of days from the first spontaneous breathing trial (SBT) or initiation of weaning protocol until successful extubation
|
From the start of the weaning process up to successful extubation (up to 30 days)
|
|
Reintubation Rate Within 72 Hours
Periodo de tiempo: Within 72 hours post-extubation
|
Percentage of patients who require reintubation within 72 hours following initial planned extubation.
|
Within 72 hours post-extubation
|
|
Length of Stay in Intensive Care Unit (ICU)
Periodo de tiempo: From study enrollment until ICU discharge (up to 30 days).
|
Total number of days the patient remains admitted to the ICU.
|
From study enrollment until ICU discharge (up to 30 days).
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- CEI2025-12V1
- REHAB-25-1 (Otro identificador: CEI2025-12V1)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .